If you didn't find what you were looking for, try a new search!
DARIEN, IL – A new study found that treating obstructive sleep apnea with CPAP therapy increased self-reported physical activity in adults with a history of heart disease. During a mean follow-up period of 3.7 years, the group treated with CPAP therapy reported approximately 20% [...]
On Feb. 5, 2021, the FDA authorized marketing of a new prescription device, eXciteOSA (formerly Snoozeal), to reduce snoring and mild obstructive sleep apnea. It is the first device used while awake that is intended to improve tongue muscle function, which in time can [...]
DARIEN, IL – As we approach flu season, adults with obstructive sleep apnea may want to take extra precautions. A study published online as an accepted paper in the Journal of Clinical Sleep Medicine is the first to find that patients with sleep apnea [...]
The American Academy of Sleep Medicine (AASM) is seeking public comments on proposed revisions to the adult obstructive sleep apnea (OSA) quality measure set, which was published in 2015 and is currently undergoing measure maintenance. The public comment period will be open for four [...]
Medicare has finalized and posted local coverage determination (LCD) policies on “Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea.” The American Academy of Sleep Medicine previously submitted feedback during the public comment periods put forth by all seven Medicare Administrative Contractors (MACs). [...]
DARIEN, IL – A study published online as an accepted paper in the Journal of Clinical Sleep Medicine found that increased physical activity is associated with a lower risk of obstructive sleep apnea, a common sleep-related breathing disorder. The study is the largest to [...]
Inspire Medical Systems, Inc. announced April 21 that the FDA has approved an expanded age range for Inspire therapy for obstructive sleep apnea, lowering the minimum age from 22 years to 18 years. Inspire therapy is used for the treatment of moderate to severe [...]
DARIEN, IL – Facial features analyzed from 3D photographs could predict the likelihood of having obstructive sleep apnea, according to a study published in the April issue of the Journal of Clinical Sleep Medicine. Using 3D photography, the study found that geodesic measurements — [...]
The American Academy of Sleep Medicine (AASM) is gathering resources for patients and the public about sleep, obstructive sleep apnea, CPAP therapy, and the novel coronavirus (COVID-19). The AASM encourages you to follow the CDC tips on how to prevent getting sick. You also [...]
Australian-based Oventus has received clearance from the U.S. Food and Drug Administration for an oral device to treat obstructive sleep apnea, according to a Sept. 2, 2019, company statement. The O2Vent Optima is a customized, 3D-printed, nylon oral device that stabilizes the patient’s upper [...]
The U.S. Food and Drug Administration has issued clearance to Resonea for an in-home sleep apnea screening device, according to a July 25, 2019, statement issued by the company. Drowzle is a prescription smartphone-based device that tracks symptoms and records breathing patterns during sleep [...]
An Israeli-based company has received clearance from the U.S. Food and Drug Administration for a new home sleep apnea test, according to a June 6, 2019, announcement from Itamar Medical. The company reports that its WatchPAT One is the first fully disposable home sleep [...]
Revised policies for seven payers were recently reviewed by the AASM Payer Policy Review Committee, which develops and continues to revise payer policy scorecards to evaluate how effective payer policies are at establishing appropriate coverage for diagnostic sleep testing services. The committee also seeks [...]
DARIEN, IL – Older adults with undiagnosed obstructive sleep apnea seek more health care, according to a study published in the January issue of the Journal of Clinical Sleep Medicine. The study examined the impact of untreated sleep apnea on health care utilization and [...]
DARIEN, IL – Treating patients with moderate or severe obstructive sleep apnea with positive airway pressure (PAP) therapy is associated with reduced acute care visits and health care expenditures, according to a recent study. Every one-hour increase in PAP usage per night was associated [...]
The American Academy of Sleep Medicine (AASM) encourages members to submit comments on proposed local coverage determination (LCD) policies for hypoglossal nerve stimulation for treatment of obstructive sleep apnea. Developed by six Medicare Administrative Contractors (MACs), the proposed LCDs are now open for public [...]
The AASM Payer Policy Review Committee has reviewed a recently revised payer policy focusing on diagnostic testing for obstructive sleep apnea in adults. The committee completed a new payer policy scorecard after evaluating the revised Sleep Disorder Management Diagnostic & Treatment Guidelines policy from [...]
Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement Abstract The diagnosis and effective treatment of obstructive sleep apnea (OSA) in adults is an urgent health priority. Positive airway pressure (PAP) therapy remains the most [...]
Obstructive Sleep Apnea Screening Health Advisory Obstructive sleep apnea (OSA) is a potentially lethal disease that increases the risk of numerous health problems, including cardiovascular disease. Patients with OSA who are diagnosed and treated with either positive airway pressure (PAP) therapy or an [...]
Marijuana and Obstructive Sleep Apnea Health Advisory Marijuana is a drug derived from the cannabis plant. The flower from the cannabis plant has nearly 100 unique active compounds. Each of these compounds can have a different effect on the brain and body. Synthetic [...]
The AASM Payer Policy Review Committee recently reviewed a policy from Horizon Blue Cross Blue Shield of New Jersey, “Diagnosis and Medical Management of Obstructive Sleep Apnea Syndrome.” The committee evaluated the policy and assigned a score based on nine criteria, aligned with the [...]
SAN ANTONIO – June 12, 2019 – Recently unemployed people with undiagnosed obstructive sleep apnea have a higher risk of having lost a job multiple times, according to preliminary results from a new study. Results show that individuals with undiagnosed obstructive sleep apnea were [...]
The AASM Payer Policy Review Committee recently reviewed a payer policy from Blue Cross Blue Shield of Wyoming, Diagnosis and Medical Management of Obstructive Sleep Apnea Syndrome. The committee evaluated the insurer policy and assigned a score based on nine criteria, aligned with the [...]
The AASM Payer Policy Review Committee recently reviewed five payer policies, focusing on diagnostic testing for obstructive sleep apnea in adults. The Committee evaluated the insurers’ policies and assigned a score based on nine criteria, aligned with the AASM’s Clinical Practice Guideline for Diagnostic [...]
DARIEN, IL – A new clinical practice guideline from the American Academy of Sleep Medicine (AASM) provides guidance to clinicians on the use of positive airway pressure (PAP) therapy to treat obstructive sleep apnea (OSA) in adults. The guideline, published in the Feb. 15 issue [...]
The AASM Payer Policy Review Committee recently developed new scorecards for five payer policies, focusing on diagnostic testing for obstructive sleep apnea (OSA) in adults. The committee evaluated the insurers’ policies and assigned a score based on nine criteria, aligned with the AASM’s Clinical [...]
DARIEN, IL – In Chicago on Saturday, Nov. 10, the American Academy of Sleep Medicine (AASM) hosted 35 representatives from 14 medical societies, nurse practitioner associations and patient advocacy groups for a one-day Sleep-Disordered Breathing Collaboration Summit to discuss strategies to improve the diagnosis [...]
DARIEN, IL - The American Academy of Sleep Medicine (AASM) and former NFL offensive lineman Aaron Taylor have partnered to launch two new public service announcements (PSAs) urging television viewers to “Defend Your Sleep” by talking to a doctor about obstructive sleep apnea – [...]
Despite the submission of AASM comments urging the Centers for Medicare & Medicaid Services (CMS) to retain all four of the AASM-stewarded sleep apnea measures in the Merit-based Incentive Payment System (MIPS), CMS finalized the removal of two measures for the 2019 reporting year and [...]
The AASM Payer Policy Review Committee recently developed new scorecards for eight payer policies, focusing on diagnostic testing for obstructive sleep apnea (OSA) in adults. The committee evaluated the insurers’ policies and assigned a score based on nine criteria, aligned with the AASM’s Clinical [...]
The Centers for Medicare and Medicaid Services (CMS) is proposing to remove two AASM-stewarded obstructive sleep apnea (OSA) measures from the Merit-based Incentive Payment System (MIPS) program for the 2021 payment year (and future years). The measures proposed for removal are: 276 – Sleep [...]
In this recorded webinar, Dr. Virend Somers reviews both historical and recent evidence of the associations, causality and therapeutic implications of obstructive sleep apnea (OSA) and cardiovascular disease. The webinar also includes a question-and-answer session with Dr. Somers, hosted by Dr. Shalini Paruthi, [...]
